Skip to Main Content

Paper Details

Paclitaxel plus Eftilagimod Alpha, a Soluble LAG-3 Protein, in Metastatic, HR+ Breast Cancer: Results from AIPAC, a Randomized, Placebo Controlled Phase IIb Trial.
Clin Cancer Res
0
2024
Author NameAffiliation
Luc Dirix
Carolien P Schr??derNetherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam and University Medical Center Groningen
  • 1 - 2

Datasets

Release 1.2